Cargando…
India’s cost-effective COVID-19 vaccine development initiatives
Autores principales: | Chakraborty, Chiranjib, Agoramoorthy, Govindasamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574682/ https://www.ncbi.nlm.nih.gov/pubmed/33129610 http://dx.doi.org/10.1016/j.vaccine.2020.10.056 |
Ejemplares similares
-
The current second wave and COVID-19 vaccination status in India
por: Chakraborty, Chiranjib, et al.
Publicado: (2021) -
SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021) -
Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
por: Chakraborty, Chiranjib, et al.
Publicado: (2023) -
Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis
por: Chakraborty, Chiranjib, et al.
Publicado: (2021) -
Stem cells in the light of evolution
por: Chakraborty, Chiranjib, et al.
Publicado: (2012)